May 29, 2019
Rose
In the first day of the high-profile opioid trial, Oklahoma Attorney General Mike Hunter confronted what many legal experts have predicted will be the highest hurdle in the case: connecting one manufacturer of opioids to the cascading harms wrought by the entire industry. Johnson & Johnson fought back, though, arguing that the state itself looked the other way as its own drug review board and prescription monitoring program for years neglected to swoop down on sources of diverted opioids.
from Kaiser Health News http://bit.ly/2VXZN16
May 29, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: VA Health Care Workers Too Often Denigrated, Stereotyped As ‘Bad Apples’; NRA Needs To Promote Research Efforts To End Gun Violence- When High-Profile People Share Alzheimer’s Diagnosis, Millions Of Others With The Disease May Benefit
- Harmful Effects Of Childhood Trauma On Later Life Call For New Public Health Policies, Researchers Say
- State Highlights: Study Finds Vast Disparity In What Colorado Hospitals Charge Over Other States; Athenahealth Agrees To Buyout From New York Financial Firms
- California Wildfire Death Toll Climbs To Become One Of Most Deadly On Record
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment